International Conference on Harmonisation; Stability Data Package for Registration Applications in Climatic Zones III and IV; Stability Testing of New Drug Substances and Products; availability. Notice.
The Food and Drug Administration (FDA) is announcing the availability of two guidances prepared under the auspices of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The first is a guidance entitled "Q1F Stability Data Package for Registration Applications in Climatic Zones III and IV'' (the Q1F guidance). The second is a revised guidance entitled "Q1A(R2) Stability Testing of New Drug Substances and Products'' (the Q1A guidance). The Q1F guidance, which is an annex to the Q1A guidance, defines an approach for broader use of the Q1A guidance for territories in climatic zones III and IV. The revised Q1A guidance incorporates relevant Q1F recommendations.
D002980:Climate; D003226:Congresses as Topic; D004345:Drug Industry / Q000592:standards*; D004355:Drug Stability; D005060:Europe; D005062:European Union; D017408:Guidelines as Topic; D006801:Humans; D006813:Humidity / Q000592:standards*; D007391:International Cooperation; D007564:Japan; D013696:Temperature; D014481:United States; D014486:United States Food and Drug Administration